ArticlePloS one2013

Combining antiangiogenic therapy with adoptive cell immunotherapy exerts better antitumor effects in non-small cell lung cancer models.

Shujing Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.